MicroRNA Expression Profile of Mouse Lung Infected with 2009 Pandemic H1N1 Influenza Virus

Zhihao Wu, Rongzhang Hao, Peng Li, Xiao‐Ai Zhang, Nan Liu, Shaofu Qiu, Ligui Wang, Yong Wang, Wenzhong Xue, Kun Liu, Guang Yang, Jiajun Cui, Chuanfu Zhang, Hongbin SongPLoS 2013 · DOI

Abstract

MicroRNAs (miRNAs) have been implicated in the regulation of gene expression across various biological processes, including host responses to viral infections. The 2009 pandemic H1N1 influenza virus is an emerging reassortant strain that can cause severe illness. To understand its molecular pathogenesis, we profiled cellular miRNAs in the lungs of BALB/c mice infected with the wild-type 2009 pandemic strain A/Beijing/501/2009 (BJ501) and the mouse-adapted A/Puerto Rico/8/1934 (PR8) strain. Microarray analysis revealed strain- and temporal-specific miRNA expression patterns. Notably, more differentially expressed (DE) miRNAs were observed on day 5 post-infection than on day 2, with a general trend toward up-regulation. We identified 47 unique DE miRNAs, including 32 with known roles in immunity and antiviral activity, such as miR-155 and miR-223. Pathway enrichment analysis identified the transforming growth factor-β (TGF-β) signaling pathway as a key cellular target. These findings provide the first miRNA expression profiles for the 2009 pandemic H1N1 virus in a mouse model, offering potential novel therapeutic targets.

Introduction

While the clinical impact of the 2009 H1N1 pandemic is well-documented, the underlying molecular "tug-of-war" between the virus and the host remains partially obscured. Specifically, the role of microRNAs—small, non-coding RNA molecules that act as post-transcriptional "dimmer switches" for gene expression—was a major knowledge gap for this specific pandemic strain. Understanding which miRNAs are activated or suppressed during infection is crucial because these molecules regulate the host's immune response, inflammation, and viral replication. By mapping these profiles, researchers can identify potential biomarkers for disease severity or novel therapeutic targets that could "re-tune" the host response to improve survival.

Materials and Methods

This study utilized a comparative approach in a BALB/c mouse model. Mice were infected with either the wild-type 2009 pandemic strain (BJ501) or a mouse-adapted laboratory strain (PR8). Lung tissues were harvested at 2 and 5 days post-infection (dpi). The research team employed Agilent Mouse miRNA microarrays to profile 938 different miRNAs. To ensure technical reliability, nine key miRNAs were validated using Real-time RT-PCR. Bioinformatics tools, including TargetScan 6.2 and DAVID 6.7, were used to predict messenger RNA (mRNA) targets and identify affected biological pathways. The resulting expression matrix has been deposited in the Gene Expression Omnibus (GEO) database under accession number GSE46087.

Results

Temporal Escalation and Up-regulation Bias

The host regulatory response showed significant temporal progression. Microarray data revealed a marked increase in the number of differentially expressed miRNAs as the infection progressed from 2 dpi to 5 dpi. Furthermore, for both viral strains, the majority of affected miRNAs were up-regulated rather than suppressed. This suggests that the host actively deploys these regulatory molecules, likely in an attempt to modulate the escalating inflammatory response as the infection moves toward full-blown pulmonary inflammation.

Figure 5: Quantification of up- and down-regulated miRNAs showing temporal escalation and a bias toward up-regulation at Day 5 post-infection.

Strain-Specific and Common miRNA Signatures

The study identified a total of 47 unique miRNAs significantly altered (at least a 2-fold change) during infection. While BJ501 and PR8 shared many regulatory features, they also exhibited strain-specific signatures. PR8 provoked a broader miRNA response (43 DE miRNAs) compared to BJ501 (29 DE miRNAs), which may correlate with differences in virulence and adaptation. Of these 47 miRNAs, 32 have known roles in cancer, immunity, or antiviral activity (such as miR-155 and miR-223), while 15 have no previously reported function.

Figure 6: Venn diagrams illustrating the common and distinct differentially expressed miRNAs between BJ501 and PR8 at 2 and 5 days post-infection.

Pathway Enrichment: The TGF-β Hub

Pathway enrichment analysis of predicted targets pointed directly to the Transforming Growth Factor-beta (TGF-β) signaling pathway as the primary target for both strains. As a master regulator of cell cycle control, inflammation, and tissue repair, the modulation of TGF-β by miRNAs likely contributes to the severe lung pathology, such as pneumonia and edema, characteristic of H1N1 infection. Other top enriched pathways included adherens junction and axon guidance, suggesting a conserved viral strategy for disrupting lung tissue integrity.

Discussion

This study provides a foundational "parts list" for the regulatory response to 2009 H1N1. However, some limitations remain. First, the lack of parallel mRNA profiling means the actual silencing effect of these miRNAs on their predicted targets remains hypothetical until confirmed by transcriptomic or proteomic data. Second, the study is primarily descriptive; future functional validation involving "knockdown" or "overexpression" experiments for candidates like miR-155 or miR-223 is necessary to determine if manipulating these molecules can reduce viral titers or lung damage in vivo. Despite these limitations, the identification of these 47 miRNAs moves the field closer to developing precision therapies for severe influenza.

Summary updated

Abstract

MicroRNAs have been implicated in the regulation of gene expression of various biological processes in a post-transcriptional manner under physiological and pathological conditions including host responses to viral infections. The 2009 pandemic H1N1 influenza virus is an emerging reassortant strain of swine, human and bird influenza virus that can cause mild to severe illness and even death. To further understand the molecular pathogenesis of the 2009 pandemic H1N1 influenza virus, we profiled cellular microRNAs of lungs from BALB/c mice infected with wild-type 2009 pandemic influenza virus A/Beijing/501/2009 (H1N1) (hereafter referred to as BJ501) and mouse-adapted influenza virus A/Puerto Rico/8/1934 (H1N1) (hereafter referred to as PR8) for comparison. Microarray analysis showed both the influenza virus BJ501 and PR8 infection induced strain- and temporal-specific microRNA expression patterns and that their infection caused a group of common and distinct differentially expressed microRNAs. Characteristically, more differentially expressed microRNAs were aroused on day 5 post infection than on day 2 and more up-regulated differentially expressed microRNAs were provoked than the down-regulated for both strains of influenza virus. Finally, 47 differentially expressed microRNAs were obtained for the infection of both strains of H1N1 influenza virus with 29 for influenza virus BJ501 and 43 for PR8. Among them, 15 microRNAs had no reported function, while 32 including miR-155 and miR-233 are known to play important roles in cancer, immunity and antiviral activity. Pathway enrichment analyses of the predicted targets revealed that the transforming growth factor-β (TGF-β) signaling pathway was the key cellular pathway associated with the differentially expressed miRNAs during influenza virus PR8 or BJ501 infection. To our knowledge, this is the first report of microRNA expression profiles of the 2009 pandemic H1N1 influenza virus in a mouse model, and our findings might offer novel therapy targets for influenza virus infection.
BibTeX
@inproceedings{wu2013microrna,
  author = {Zhihao Wu and Rongzhang Hao and Peng Li and Xiao‐Ai Zhang and Nan Liu and Shaofu Qiu and Ligui Wang and Yong Wang and Wenzhong Xue and Kun Liu and Guang Yang and Jiajun Cui and Chuanfu Zhang and Hongbin Song},
  title = {{MicroRNA Expression Profile of Mouse Lung Infected with 2009 Pandemic H1N1 Influenza Virus}},
  booktitle = {PLoS},
  year = {2013},
  doi = {10.1371/journal.pone.0074190},
}
Figure